TY - JOUR
T1 - Maternal and perinatal outcomes in obese pregnant women
AU - Suherman, Rachma Wulan Pratiwi
AU - Akbar, Muhammad Ilham Aldika
N1 - Publisher Copyright:
© 2025 by SPC
PY - 2025/7
Y1 - 2025/7
N2 - Obesity constitutes a global epidemic with increasing prevalence, associated with considerable health complications. Obese pregnant women are at increased risk for maternal and perinatal complications. This study explores the characteristics of maternal and perinatal outcomes in obese pregnant women at Dr. Soetomo General Hospital and Airlangga University Hospital, Surabaya, in 2023.This study was a descriptive and observational analysis of pregnant women with obesity who delivered at Dr. Soetomo General Hospital and Airlangga University Hospital Surabaya in 2023. The study samples were classified into three categories according to obesity classes: Class I (BMI 30-34.9), Class II (BMI 35-39.9), and Class III (BMI ≥40), and maternal and perinatal outcomes were assessed.Out of 512 subjects, the majority were from Airlangga University Hospital (75%), and 90% lived in Surabaya. 64.1% were classified as class I obesity, and 67.8% were multigravida. 53.3% delivered by cesarean section. The most common pregnancy complication was preeclampsia (23.2%), followed by gestational DM (7.6%), gestational HT (6.4%), and eclampsia (2%). There were 2.7% of subjects who experienced postpartum hemorrhage during labor, and 0.2% experienced shoulder dystocia. In terms of perinatal outcomes, 21.5% of infants had an Apgar score < 7 at 1 minute and 7.4% at 5 minutes. FGR affected 6.6% of infants, macrosomia affected 2%, congenital anomalies affected 5.1%, and the NICU admitted 15% of them. Significant differences were observed in maternal outcomes of preeclampsia, eclampsia, and mode of delivery across the three obesity classes, alongside notable differences in perinatal outcomes related to macrosomia and NICU admission (p<0.05).
AB - Obesity constitutes a global epidemic with increasing prevalence, associated with considerable health complications. Obese pregnant women are at increased risk for maternal and perinatal complications. This study explores the characteristics of maternal and perinatal outcomes in obese pregnant women at Dr. Soetomo General Hospital and Airlangga University Hospital, Surabaya, in 2023.This study was a descriptive and observational analysis of pregnant women with obesity who delivered at Dr. Soetomo General Hospital and Airlangga University Hospital Surabaya in 2023. The study samples were classified into three categories according to obesity classes: Class I (BMI 30-34.9), Class II (BMI 35-39.9), and Class III (BMI ≥40), and maternal and perinatal outcomes were assessed.Out of 512 subjects, the majority were from Airlangga University Hospital (75%), and 90% lived in Surabaya. 64.1% were classified as class I obesity, and 67.8% were multigravida. 53.3% delivered by cesarean section. The most common pregnancy complication was preeclampsia (23.2%), followed by gestational DM (7.6%), gestational HT (6.4%), and eclampsia (2%). There were 2.7% of subjects who experienced postpartum hemorrhage during labor, and 0.2% experienced shoulder dystocia. In terms of perinatal outcomes, 21.5% of infants had an Apgar score < 7 at 1 minute and 7.4% at 5 minutes. FGR affected 6.6% of infants, macrosomia affected 2%, congenital anomalies affected 5.1%, and the NICU admitted 15% of them. Significant differences were observed in maternal outcomes of preeclampsia, eclampsia, and mode of delivery across the three obesity classes, alongside notable differences in perinatal outcomes related to macrosomia and NICU admission (p<0.05).
KW - Maternal obesity
KW - Maternal outcomes
KW - Obesity
KW - Perinatal outcomes
UR - http://www.scopus.com/inward/record.url?scp=85210082597&partnerID=8YFLogxK
U2 - 10.48309/jmpcr.2025.482620.1462
DO - 10.48309/jmpcr.2025.482620.1462
M3 - Article
AN - SCOPUS:85210082597
SN - 2981-0221
VL - 7
SP - 1336
EP - 1348
JO - Journal of Medicinal and Pharmaceutical Chemistry Research
JF - Journal of Medicinal and Pharmaceutical Chemistry Research
IS - 7
ER -